Stock Chart

TNDM

$20.09 +1.01%
Score: 57.9 HOLD
LEAPs: SELL $28
i
LEAPs Option Signal

Type: SELL wallstreet
Strike: $28
Premium: $4.91
Expiry: Jan 15, 2027
Target: $26
Score: -100

LEAPs are long-term options (1+ year) with less time decay.
30D Target: $17.19 - $23.48 STRONG_UPTREND
i
30D Trendline Target

This is a PROJECTED price range based on extrapolating the current trendline slope forward 30 days.

How it works:
• Draws support and resistance trendlines
• Calculates slope (rate of change)
• Projects lines to 30 days future

Signals:
● STRONG_UPTREND: Steep rise
● UPTREND: Moderate rise
● SIDEWAYS: Flat/Mixed
● DOWNTREND: Falling

⚠️ Not a prediction. Shows trend projection only.

R-squared: 0.80
Vol: 0.87x (vs SPY: 0.9x | vs QQQ: 1.0x)
Volume Ratio Explained

Vol: Current volume vs 20-day average
vs SPY: Relative activity vs market
vs QQQ: Relative activity vs tech

Color Guide:
● Red (≥1.5x): High activity
● Yellow (≥1.2x): Above average
● Blue (≤0.7x): Low activity

Interpretation:
• vs SPY > 1: Stock-specific interest
• vs SPY < 1: Stock quiet vs market
Technical Chart
CHART OVERLAYS
Active: 2
INDICATORS
TRENDLINES
OPTIONS FLOW
VOLUME & PRICE
OTHER

About TNDM - Tandem Diabetes Care, Inc.

Tandem Diabetes designs, manufactures, and markets durable insulin pumps for individuals with diabetes. The firm first entered this market in 2012 and has since introduced multiple generations of pumps leading to its current t:slim X2 device. The firm recently launched its smaller Mobi pump and continues to work on Tobi (a tubeless version of Mobi), and the Sigi tubeless patch pump. Nearly three-quarters of total revenue is derived from the US, with the remainder primarily from other developed nations. The …

Key Statistics

Market Cap $1B

This TNDM stock chart provides comprehensive technical analysis including candlestick patterns, volume profile analysis, and options open interest data. Track TNDM's price movements with trendlines, gamma walls, and key support/resistance levels.